Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trialSeong‐Ho Koh, Kyu‐Yong Lee, Seong Hye Choi et al.|Alzheimer s Research & Therapy|2021Cited by 38